Partner Content Partner Content Exclusive interview with AstraZeneca ahead of upcoming Weara... Wearable Injectors & Connected Devices
Partner Content Partner Content Conference brochure for the inaugural Respiratory Drug Deliv... Conference brochure for the inaugural Respiratory Drug
Partner Content Partner Content Department for International Trade to present at Wearable In... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content Registration is Live for the Inaugural Respiratory Drug Deli... Registration is Live for the Inaugural Respiratory Drug
Partner Content Partner Content Exclusive Interview with Dr Zisis Kozlakidis ahead of Bioban... Dr Zisis Kozlakidis Head of Laboratories and Biobanking
Partner Content Partner Content AstraZeneca to lead a workshop during the Wearable Injectors... Wearable Injectors and Connected Devices Conference
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
